Test Lists

  • Regression Package Testing List Page
Publisher QA3 - UPP Test
  • Regression Package Testing List Page
1 / 0

Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study

October 30, 2020
By Microvascular Health Solutions
Alt Text FF - Home Screen Icon 3
Caption FF
Description FF
Share this...
  • Facebook
  • Pinterest
  • Twitter
  • Linkedin

ALPINE, Utah, Oct. 30, 2020 /PRNewswire/ — Research reveals that COVID-19 patients have severe damage to microcirculation and the endothelial glycocalyx. The data in a newly released study clearly show severe reduction of microcirculation and the endothelial glycocalyx in patients with COVID-19 and underscores the importance of healthy microcirculation and capillaries. This study was possible because of GlycoCheck, a new groundbreaking medical device from Microvascular Health Solutions.

The study’s finding has fueled the hypothesis that COVID-19 is actually a vascular illness and that systemic leakiness and impairment of the endothelial glycocalyx might play a central role in the development of acute respiratory distress syndrome (ARDS) and multi-organ failure.

Capillaries are lined with a gel-like lining called the endothelial glycocalyx. When they are in good health the glycocalyx enables delivery of essential oxygen and nutrients to all vital organs. When microcirculation is severely impaired, as is the case for critically ill COVID-19 patients, lung function is significantly reduced, and mechanical ventilation is required for them to breathe.

The study was overseen by University Hospital Munster in Germany and compared three groups:

  1. COVID-19 patients without need for mechanical ventilation
  2. COVID-19 patients requiring mechanical ventilation
  3. Control group of healthy people.

The study reveals:

  • Up to 95% of the smallest capillaries – the tiniest part of microcirculation – have been severely damaged in patients on mechanical ventilators. About 100 capillaries fit inside a human hair.
  • Up to 65% of the smallest capillaries have been severely damaged in patients who aren’t on ventilation.

With a large percentage of the smallest capillaries having been severely damaged, oxygen cannot be transported from the lungs to the rest of the body.

GlycoCheck testing is non-invasive. A video microscope camera is placed under the tongue where microvessels are representative of the entire body. In minutes, 100,000 vessels are measured, with 1,000 measurements calculated per vessel. There are over 100 million calculations from the test.

The GlycoCheck test measures the interaction of red blood cells with the surface of the endothelial glycocalyx, expressed as the perfused boundary region (PBR). Increases in PBR reflect damage to the glycocalyx. This parameter was developed by Dr. Hans Vink, PhD, a glycocalyx research pioneer who has studied the glycocalyx for more than three decades. Dr. Vink considers PBR to be the “canary in the coal mine” that reveals if the glycocalyx has become thin and damaged.

GlycoCheck combines the PBR measurement with density of capillaries, and capillary recruitment capacity, which is how capillary density increases at higher levels of blood flow. Together, these three measurements analyze microvascular health and objectively report a single systemic MicroVascular Health Score™.

The glycocalyx becomes damaged because of risk factors such as aging, genetics, obesity, stress, pollution, smoking, and vaping. Researchers in 90 hospitals worldwide use GlycoCheck to link a damaged glycocalyx with heart disease, kidney disease, stroke, hypertension, diabetes, and other conditions. With this study, COVID-19 can also be linked to a severely damaged glycocalyx.

Media Contact: Gary Hennerberg – ghennerberg@microvascular.com

Related Images

healthy-vs-unhealthy.jpg
Healthy vs Unhealthy Microcirculation
Real footage from a GlycoCheck Test

Related Links

Microvascular Health Solutions

GlycoCheck

Categories: Madison Magazine Logo

Latest Stories

Eu Regulator Authorizes Astrazeneca Vaccine For All Adults

EU regulator authorizes AstraZeneca vaccine for all adults

Rayos Syndication User,
KXLY-Latest Stories

Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.

Ex Fbi Lawyer Given Probation For Russia Probe Actions

Ex-FBI lawyer given probation for Russia probe actions

Rayos Syndication User,
KXLY-Latest Stories

WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.

Evers: Repealing Mask Mandate Like Eliminating Speed Limits

Evers: Repealing mask mandate like eliminating speed limits

Rayos Syndication User,
KXLY-Latest Stories

MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.

Conservatives Praise South Carolina Win On Abortion Ban

Conservatives praise South Carolina win on abortion ban

Rayos Syndication User,
KXLY-Latest Stories

COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.

Moscow Court Puts Navalny’s Allies Under House Arrest

Moscow court puts Navalny's allies under house arrest

Rayos Syndication User,
KXLY-Latest Stories

A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.

Most Popular

9:40 Future Import Test

One more current test NW

Current UPP Import NW

Test New Article 12092025 - 4 - Message

Test New Article 12092025 - 4 - Election

Test New Article 12092025 - 2 - Closing

© 2026 Publisher QA3 – UPP Test.

Privacy Policy
Powered byBLOX Digital
X